|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Current status of excision repair cross complementing-group 1(ERCC1) in cancer显示文摘 | Gossage L Madhusudan S | 2007 | Cancer Treat Rev2007，33，： | 1 |
| 2 | Current status of excision repair cross complementing-group 1 (ERCCI) in cancer显示文摘 | Gossage L Madhusudan S | 2007 | Cancer Treat Rev2007，33，6： | 1 |
| 3 | Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian,gastro-oesophageal and pancreatico-biliary cancers显示文摘 | Al-Attar A Gossage L Fareed KR | 2010 | Br J Cancer2010，102，4： | 1 |
| 4 | Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1 c in clear cell renal cell carcinoma 显示文摘 | Gossage L Murtaza M Slatter A F | 2014 | Genes Chromosomes Cancer2014，53，1： | 1 |
| 5 | Current status of excision re- pair cross complementing-group I (ERCCI) in Cancer 显示文摘 | Gossage L Madhusudan S | 2007 | Cancer Treat Rev2007，33，6： | 1 |
| 6 | Current status of excision re pair cross eompementing-groupl (ERCC1) in cancer显示文摘 | Gossage L Madhusudan S | 2007 | Cancer Trea Rev2007，33，56： | 1 |
| 7 | Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-esophageal and pancreatico-biliary cancers 显示文摘 | A1l-Attar A Gossage L Fareed K R | 2010 | Br J Cancer2010，102，4： | 1 |
| 8 | Diaminoarylnickel (Ⅱ) 'Pincer' complexes:mechanistic considerations in the kharasch addition reaction,controlled polymerization,and dendrimeric transition metal catalysts显示文摘 | Gossage R A van de Kuil L A van Koten G | | 0，，07： | 1 |
| 9 | Current status of excision repair cross complement group 1(ERCC1) in cancer显示文摘 | Gossage L Madh Usudan S | 2007 | Cancer Treat Rev2007，33，： | 1 |
| 10 | Diaminoarylnickel(II)'pincer” complexes:Mechanistic considerations in the kharasch addition reaction,controlled polymerization,and dendrimeric transition metal catalysts显示文摘 | Gossage R A Van de Kuil L A Van Koten G | | 0，，： | 1 |
| 11 | Current status of excision repair cross complementing-group 1 ( ERCC1 ) in cancer 显示文摘 | Gossage L Madhusudan S | 2007 | Cancer Treat Rev2007，33，6： | 1 |
| 12 | VHL, the story of a tumour suppressor gene显示文摘 | Gossage L Eisen T Maher E R | 2015 | Nat Rev Cancer2015，15，1： | 1 |
| 13 | Fetal alcohol syndrome epidemiology in a South African community:a second study of a very high prevalence area显示文摘 | Viljoen DL Gossage JP Brooke L | | 0，，05： | 1 |
| 14 | Current status of excision repair cross complementing-group I (ERCC1) in cancer 显示文摘 | Gossage L Madhusudan S | 2007 | Cancer Treat Rev2007，33，6： | 1 |
| 15 | Current Status of Excision Repair Cross Complementing-group 1 (ERCC1) in Cancer显示文摘 | Gossage L Madhusudan S | 2007 | Cancer Treat Rev2007，33，6： | 1 |
| 16 | Human apurinic/apyrim- idinic endonuclease (APE1) is a prognostic factor in ovarian, gas- trooesophageal and pancreatlco - biliary cancers 显示文摘 | A1 - Attar A Gossage L Fareed KR | 2010 | Br ] Cancer2010，102，4： | 1 |
| 17 | Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARIDIc in clear cell renal cell carcinoma显示文摘 | GOSSAGE L MURTAZA M SLATTER A F | 2014 | Genes Chromosomes Cancer2014，53，1： | 1 |
| 18 | Current status of excision repair cross complementing-group 1 ( ERCC1 ) in cancer 显示文摘 | Gossage L Madhusudan S | 2007 | Cancer Treat Rev2007，33，6： | 1 |
| 19 | Expression ofkey hypoxia sensing prolyl-hydroxylases PHD1,-2 and-3in pancreaticobiliary cancer显示文摘 | Gossage L Zaitoun A Fareed KR | 2010 | Histopathology2010，56，7： | 1 |
| 20 | Cancer phamacogenomics: role of DNA repaer genetic polymorphisms in individualizing cancer therapy显示文摘 | Gossage L Madhusudan S | 2007 | Mol Diagn Ther2007，11，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员